Abstract: Poster Presentations |


Jaime Signes-Costa, MD*; Monica Llombart, MD; Eusebi Chiner, MD; Cristina Senent, MD; Ada Luz Andreu, MD; Elia Gomez-Merino, MD; Ana Camarasa, MD; Jose Norberto Sancho, MD; Juan Manuel Arriero, MD
Author and Funding Information

Neumologia, Hospital Universitario San Juan, San Juan de Alicante, Spain


Chest. 2007;132(4_MeetingAbstracts):526b. doi:10.1378/chest.132.4_MeetingAbstracts.526b
Text Size: A A A
Published online


PURPOSE: Tobacco has been advocated as the main cause of COPD. Smoking cessation is the only effective treatment in reducing the accelerated decline in FEV1. The aim of this study was to analyze long term abstinence rates and lung function decline in COPD patients.

METHODS: A group of 62 patients, treated in our Tobacco Clinic 5 years ago, were contacted by phone or by mail and another appointment was offered. A standardized medical questionnaire including nicotine dependence issues was administered. Self reported smoking status was validated by exhaled carbon monoxide (CO). Spirometry and radiography of the chest were performed in all patients. Quantitative data were described using mean (SD) values. Unpaired and paired t tests were used to compare groups and differences in FEV1.

RESULTS: Eight patients died (age 63.6±7.9) in the initial group (3 cancer, 1 COPD exacerbation and 4 without data). Only 23 patients of the remaining 54 came to the Clinic and they were classified as current smokers (group A) or ex-smokers (group B). Those who did not attend the appointment were considered smokers for the final analysis. There were no differences at baseline visit (5 years ago) between A and B, regarding age, number of cigarettes, Fägerstrom test, Richmond test, BMI and treatment for nicotine dependence (NRT, multicomponent psychological program or bupropion); but differences were found in pulmonary function test, being B more severe than A, (FEV1%: 51±12 v 75±20, p<0.001). Abstinence rate was 14% (8/54) at 5 years. Spirometric values showed a decrease in both groups but only significant in current smokers. Group A; FVC%: 81±15 v 75±19, p<0.001; FEV1%: 75±20 v 62±17, p<0.001. Group B; FVC%: 77±11 v 76±11, p=0.4; FEV1%: 51±12 v 48±16, p<0.1.

CONCLUSION: We conclude that COPD patients show low abstinence rate at 5 years. Those who keep smoking suffer a 13% decrease in FEV1 for only a 3% in quitters.

CLINICAL IMPLICATIONS: Tobacco quitting in COPD patients is paramount to avoid the decline in pulmonary function.

DISCLOSURE: Jaime Signes-Costa, No Financial Disclosure Information; No Product/Research Disclosure Information

Wednesday, October 24, 2007

12:30 PM - 2:00 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543